Publications searcher The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points. Fulltext search Alphabetic A-Z Alphabetic Z-A A new risk of bias checklist applicable to randomized trials, observational studies and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events. PMID: 28487158 Journal: JOURNAL OF CLINICAL EPIDEMIOLOGY Year: 2017 Reference: J Clin Epidemiol. 2017 Jun;86:168-175. doi: 10.1016/j.jclinepi.2017.04.023. Epub 2017 May 6. Impact factor: 4.978 Publication type: Paper in international publication Authors: Faillie, Jean-Luc, Ferrer, Pili, Gouverneur, Amandine, Driot, Damien, Berkemeyer, Shoma, Vidal, Xavier, Martinez-Zapata, Maria Jose, Huerta, Consuelo, Rottenkolber, Marietta, Schmiedl, Sven et al. DOI: 10.1016/j.jclinepi.2017.04.023 A new risk of bias checklist applicable to randomized trials, observational studies and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events. PMID: 28487158 Journal: JOURNAL OF CLINICAL EPIDEMIOLOGY Year: 2017 Reference: J Clin Epidemiol. 2017 Jun;86:168-175. doi: 10.1016/j.jclinepi.2017.04.023. Epub 2017 May 6. Impact factor: Publication type: Paper in international publication Authors: Ballarin, Elena; Berkemeyer, Shoma; Castells, Xavier; Driot, Damien; Faillie, Jean-Luc; Ferrer, Pili; Gouverneur, Amandine; Huerta, Consuelo; Ibanez, Luisa; Martinez-Zapata, Maria Jose et al. DOI: 10.1016/j.jclinepi.2017.04.023 A new two-step algorithm for the treatment of COPD. PMID: 28179443 Journal: EUROPEAN RESPIRATORY JOURNAL Year: 2017 Reference: Eur Respir J. 2017 Feb 8;49(2). pii: 1602200. doi: 10.1183/13993003.02200-2016. Print 2017 Feb. Impact factor: 10.569 Publication type: Letter or abstract Authors: Miravitlles, Marc, Anzueto, Antonio et al. DOI: 10.1183/13993003.02200-2016 A new two-step algorithm for the treatment of COPD. PMID: 28179443 Journal: EUROPEAN RESPIRATORY JOURNAL Year: 2017 Reference: Eur Respir J. 2017 Feb 8;49(2). pii: 1602200. doi: 10.1183/13993003.02200-2016. Print 2017 Feb. Impact factor: Publication type: Letter or abstract Authors: Anzueto, Antonio; Miravitlles, Marc et al. DOI: 10.1183/13993003.02200-2016 A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats. PMID: 28084470 Journal: Scientific Reports Year: 2017 Reference: Sci Rep. 2017 Jan 13;7:40461. doi: 10.1038/srep40461. Impact factor: 4.259 Publication type: Paper in international publication Authors: Rodriguez, Sarai, Raurell, Imma, Torres-Arauz, Manuel, Garcia-Lezana, Teresa, Genesca, Joan, Martell, Maria et al. DOI: 10.1038/srep40461 A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats. PMID: 28084470 Journal: Scientific Reports Year: 2017 Reference: Sci Rep. 2017 Jan 13;7:40461. doi: 10.1038/srep40461. Impact factor: Publication type: Paper in international publication Authors: Garcia-Lezana, Teresa; Genesca, Joan; Martell, Maria; Raurell, Imma; Rodriguez, Sarai; Torres-Arauz, Manuel et al. DOI: 10.1038/srep40461 A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4+ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients. PMID: 28698276 Journal: mBio Year: 2017 Reference: MBio. 2017 Jul 11;8(4). pii: e00876-17. doi: 10.1128/mBio.00876-17. Impact factor: 6.956 Publication type: Paper in international publication Authors: Buzon, Maria J, Crespo, Manuel, Falco, Vicenc, Grau-Exposito, Judith, Miguel, Lucia, Navarro, Jordi, Curran, Adria, Burgos, Joaquin, Ocana, Imma, Ribera, Esteban et al. DOI: 10.1128/mBio.00876-17 A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4+ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients. PMID: 28698276 Journal: mBio Year: 2017 Reference: MBio. 2017 Jul 11;8(4). pii: e00876-17. doi: 10.1128/mBio.00876-17. Impact factor: Publication type: Paper in international publication Authors: Badia, Rosa; Burgos, Joaquin; Buzon, Maria J; Castellvi, Josep; Crespo, Manuel; Curran, Adria; Falco, Vicenc; Grau-Exposito, Judith; Miguel, Lucia; Navarro, Jordi et al. DOI: 10.1128/mBio.00876-17 A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with 30% blasts. PMID: 28546581 Journal: LEUKEMIA Year: 2017 Reference: Leukemia. 2017 Dec;31(12):2799-2806. doi: 10.1038/leu.2017.159. Epub 2017 May 26. Impact factor: 11.702 Publication type: Paper in international publication Authors: Illes, A, Garcia-Manero, G, Sekeres, M A, Egyed, M, Breccia, M, Graux, C, Cavenagh, J D, Salman, H, Stauder, R, Yee, K et al. DOI: 10.1038/leu.2017.159 A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with 30% blasts. PMID: 28546581 Journal: LEUKEMIA Year: 2017 Reference: Leukemia. 2017 Dec;31(12):2799-2806. doi: 10.1038/leu.2017.159. Epub 2017 May 26. Impact factor: Publication type: Paper in international publication Authors: Acharyya, S; Borbenyi, Z; Breccia, M; Cavenagh, J D; DeAngelo, D J; Egyed, M; Fenaux, P; Garcia-Manero, G; Gazi, L; Graux, C et al. DOI: 10.1038/leu.2017.159 A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer. PMID: 28899363 Journal: BMC CANCER Year: 2017 Reference: BMC Cancer. 2017 Sep 12;17(1):646. doi: 10.1186/s12885-017-3641-6. Impact factor: 3.288 Publication type: Paper in international publication Authors: Reynolds, Kerry Lynn, Bedard, Philippe L, Lee, Se-Hoon, Lin, Chia-Chi, Tabernero, Josep, Alsina, Maria, Cohen, Ezra, Baselga, Jose, Blumenschein, George Jr, Graham, Donna M et al. DOI: 10.1186/s12885-017-3641-6 A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer. PMID: 28899363 Journal: BMC CANCER Year: 2017 Reference: BMC Cancer. 2017 Sep 12;17(1):646. doi: 10.1186/s12885-017-3641-6. Impact factor: Publication type: Paper in international publication Authors: Alsina, Maria; Bang, Yung-Jue; Baselga, Jose; Bedard, Philippe L; Blumenschein, George Jr; Cohen, Ezra; Fernandez, Rose; Garrido-Laguna, Ignacio; Graham, Donna M; Juric, Dejan et al. DOI: 10.1186/s12885-017-3641-6 A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS. PMID: 28592615 Journal: ONCOLOGIST Year: 2017 Reference: Oncologist. 2017 Sep;22(9):1024-e89. doi: 10.1634/theoncologist.2017-0175. Epub 2017 Jun 7. Impact factor: 4.962 Publication type: Paper in international publication Authors: Lieu, Christopher H, Hidalgo, Manuel, Berlin, Jordan D, Ko, Andrew H, Cervantes, Andres, LoRusso, Patricia, Gerber, David E, Eder, J Paul, Eckhardt, S Gail, Kapp, Amy V et al. DOI: 10.1634/theoncologist.2017-0175 A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS. PMID: 28592615 Journal: ONCOLOGIST Year: 2017 Reference: Oncologist. 2017 Sep;22(9):1024-e89. doi: 10.1634/theoncologist.2017-0175. Epub 2017 Jun 7. Impact factor: Publication type: Paper in international publication Authors: Berlin, Jordan D; Cervantes, Andres; Eckhardt, S Gail; Eder, J Paul; Gerber, David E; Hidalgo, Manuel; Kapp, Amy V; Ko, Andrew H; Lieu, Christopher H; LoRusso, Patricia et al. DOI: 10.1634/theoncologist.2017-0175 A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C. PMID: 28527133 Journal: INVESTIGATIONAL NEW DRUGS Year: 2017 Reference: Invest New Drugs. 2017 Oct;35(5):634-641. doi: 10.1007/s10637-017-0473-9. Epub 2017 May 19. Impact factor: 3.484 Publication type: Clinical guide Authors: Almhanna, Khaldoun, Wright, David, Mercade, Teresa Macarulla, Van Laethem, Jean-Luc, Gracian, Antonio Cubillo, Guillen-Ponce, Carmen, Faris, Jason, Lopez, Carolina Muriel, Hubner, Richard A, Bendell, Johanna et al. DOI: 10.1007/s10637-017-0473-9 A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C. PMID: 28527133 Journal: INVESTIGATIONAL NEW DRUGS Year: 2017 Reference: Invest New Drugs. 2017 Oct;35(5):634-641. doi: 10.1007/s10637-017-0473-9. Epub 2017 May 19. Impact factor: Publication type: Clinical guide Authors: Almhanna, Khaldoun; Bendell, Johanna; Bols, Alain; Danaee, Hadi; Enzinger, Peter; Faris, Jason; Fasanmade, Adedigbo; Feliu, Jaime; Gracian, Antonio Cubillo; Guillen-Ponce, Carmen et al. DOI: 10.1007/s10637-017-0473-9 A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer. PMID: 28911091 Journal: ANNALS OF ONCOLOGY Year: 2017 Reference: Ann Oncol. 2017 Sep 1;28(9):2142-2148. doi: 10.1093/annonc/mdx275. Impact factor: 11.855 Publication type: Paper in international publication Authors: Esko, V, Abdalla, K, Verma, U, Benedetti, F, Aoyama, T, Mizuguchi, H, Makris, L, Rosati, G, Elme, A, Feliu, J et al. DOI: 10.1093/annonc/mdx275 A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer. PMID: 28911091 Journal: ANNALS OF ONCOLOGY Year: 2017 Reference: Ann Oncol. 2017 Sep 1;28(9):2142-2148. doi: 10.1093/annonc/mdx275. Impact factor: Publication type: Paper in international publication Authors: Abdalla, K; Abramov, M; Ajani, J A; Alsina, M; Aoyama, T; Benedetti, F; Bondarenko, I; Elme, A; Esko, V; Feliu, J et al. DOI: 10.1093/annonc/mdx275 A population-based analysis of predictors of influenza vaccination uptake in pregnant women: The effect of gestational and calendar time. PMID: 28216380 Journal: PREVENTIVE MEDICINE Year: 2017 Reference: Prev Med. 2017 Jun;99:111-117. doi: 10.1016/j.ypmed.2017.02.010. Epub 2017 Feb 16. Impact factor: 3.434 Publication type: Paper in international publication Authors: Campins, Magda, Vilca, Luz Maria, Verma, Aman, Buckeridge, David et al. DOI: 10.1016/j.ypmed.2017.02.010 A population-based analysis of predictors of influenza vaccination uptake in pregnant women: The effect of gestational and calendar time. PMID: 28216380 Journal: PREVENTIVE MEDICINE Year: 2017 Reference: Prev Med. 2017 Jun;99:111-117. doi: 10.1016/j.ypmed.2017.02.010. Epub 2017 Feb 16. Impact factor: Publication type: Paper in international publication Authors: Buckeridge, David; Campins, Magda; Verma, Aman; Vilca, Luz Maria et al. DOI: 10.1016/j.ypmed.2017.02.010 A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease. PMID: 29183382 Journal: RESPIRATORY RESEARCH Year: 2017 Reference: Respir Res. 2017 Nov 28;18(1):198. doi: 10.1186/s12931-017-0682-y. Impact factor: 3.841 Publication type: Review in national publication Authors: Miravitlles, Marc, Cosio, Borja G, Arnedillo, Aurelio, Calle, Myriam, Alcazar-Navarrete, Bernardino, Gonzalez, Cruz, Esteban, Cristobal, Trigueros, Juan Antonio, Rodriguez Gonzalez-Moro, Jose Miguel, Quintano Jimenez, Jose Antonio et al. DOI: 10.1186/s12931-017-0682-y A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease. PMID: 29183382 Journal: RESPIRATORY RESEARCH Year: 2017 Reference: Respir Res. 2017 Nov 28;18(1):198. doi: 10.1186/s12931-017-0682-y. Impact factor: Publication type: Review in national publication Authors: Alcazar-Navarrete, Bernardino; Arnedillo, Aurelio; Baloira, Adolfo; Calle, Myriam; Cosio, Borja G; Esteban, Cristobal; Gonzalez, Cruz; Miravitlles, Marc; Quintano Jimenez, Jose Antonio; Rodriguez Gonzalez-Moro, Jose Miguel et al. DOI: 10.1186/s12931-017-0682-y A Prospective International Aspergillus terreus Survey: An EFISG, ISHAM and ECMM Joint Study. PMID: 28412383 Journal: CLINICAL MICROBIOLOGY AND INFECTION Year: 2017 Reference: Clin Microbiol Infect. 2017 Oct;23(10):776.e1-776.e5. doi: 10.1016/j.cmi.2017.04.012. Epub 2017 Apr 13. Impact factor: 5.292 Publication type: Paper in international publication Authors: Zoran, Tamara, Lackner, Michaela, Aigner, Maria, Sanchez-Reus, Ferran, Rezusta, Antonio, Chowdhary, Anuradha, Taj-Aldeen, Saad Jaber, Arendrup, Maiken C, Oliveri, Salvatore, Kontoyiannis, Dimitrios P et al. DOI: 10.1016/j.cmi.2017.04.012 A Prospective International Aspergillus terreus Survey: An EFISG, ISHAM and ECMM Joint Study. PMID: 28412383 Journal: CLINICAL MICROBIOLOGY AND INFECTION Year: 2017 Reference: Clin Microbiol Infect. 2017 Oct;23(10):776.e1-776.e5. doi: 10.1016/j.cmi.2017.04.012. Epub 2017 Apr 13. Impact factor: Publication type: Paper in international publication Authors: Aigner, Maria; Alastruey-Izquierdo, Ana; Arendrup, Maiken C; Arikan-Akdagli, Sevtap; Arsic-Arsenijevic, Valentina; Badali, Hamid; Buzina, Walter; Chakrabarti, Arunaloke; Chowdhary, Anuradha; Colombo, Arnaldo L et al. DOI: 10.1016/j.cmi.2017.04.012 Pagination First page « First Previous page ‹ Previous … Page 945 Page 946 Page 947 Page 948 Current page 949 Page 950 Page 951 Page 952 Page 953 … Next page Next › Last page Last »
